The AUC of anti-FTL to distinguish LC from CH or healthy subjects were 0.654 (95% CI: 0.615-0.692) and 0.642 (95% CI: 0.602-0.681), respectively. Anti-FTL is not a biomarker for the early diagnosis of HCC due to specificity deficiency, but may be helpful for the early detection of LC.